APA (7th ed.) Citation

Garrison Lovett & Stephen Hsu. (2024). EC16 Nanoformulation: A Potential Nasal Drug for Treating Long COVID. Elsevier.

Chicago Style (17th ed.) Citation

Garrison Lovett and Stephen Hsu. EC16 Nanoformulation: A Potential Nasal Drug for Treating Long COVID. Elsevier, 2024.

MLA (9th ed.) Citation

Garrison Lovett and Stephen Hsu. EC16 Nanoformulation: A Potential Nasal Drug for Treating Long COVID. Elsevier, 2024.

Warning: These citations may not always be 100% accurate.